Special Issue "The Role of Chemokines in Inflammatory Pathologies"

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: closed (1 April 2018)

Special Issue Editors

Guest Editor
Dr. Christina Bursill

South Australian Health and Medical Research Institute, and Department of Health and Medical Sciences—The University of Adelaide, Adelaide, SA, Australia
Website | E-Mail
Interests: chemokine biology; atherosclerosis; angiogenesis; lipoproteins
Guest Editor
Dr. Joanne Tan

Sydney Medical School, The University of Sydney, Sydney, NSW, Australia
Website | E-Mail
Interests: virology; molecular biology; immunology; blood transfusion

Special Issue Information

Dear Colleagues, 

Chemokines play diverse and complex roles in a host of different inflammatory diseases, including wound repair, cancer, retinopathy, atherosclerosis, multiple sclerosis, inflammatory bowel disease, and allergy. The primary role of chemokines is to direct the migration of cells to sites of inflammation or injury in order to clear pathogens or unwanted modified lipids or proteins. Dysregulation of this process can, however, exacerbate disease. This has led to a host of different strategies designed to block chemokine activity. There are approximately 50 chemokines to date and whilst it was initially thought that there was a large amount of redundancy in chemokine signalling, more recent evidence points to more specific roles for each chemokine and chemokine receptor interaction. This therefore highlights the importance of understanding the function of each individual chemokine in more detail so the chemokine-directed therapies can be designed to target disease with great specificity and not incur unwanted off target effects.

We invite scientists focussing on chemokine regulation in inflammatory pathologies to submit their original work or reviews. Both translational and basic research papers are welcome.

Dr. Christina Bursill
Dr. Joanne Tan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 650 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • chemokines
  • inflammatory disease
  • chemokine inhibitors

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to Top